Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 47,000 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Follow-Up Questions
Medicover AB のCEOは誰ですか？
Mr. John Stubbington は Medicover AB の Chief Executive Officer で、2025 から在籍しています。
MCVEY の株価パフォーマンスは？
MCVEY の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Medicover AB の主な事業テーマや業界は？
Medicover AB は Health Care 業界、セクターは Health Care に属しています。
